We are live on ! Find out more
NSPR icon

InspireMD

7 hedge funds and large institutions have $512K invested in InspireMD in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more capital invested

Capital invested by funds: $149K → $512K (+$363K)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

133% more funds holding

Funds holding: 37 (+4)

1.15% more ownership

Funds ownership: 0.21%1.35% (+1.1%)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NSPR Hedge Fund Activity: Q3 2019 in Review

7 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2019, worth a combined $512K — up 244% from $149K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NSPR positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $805K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $82K sold.

  • 7 institutional investors held InspireMD (NSPR) as of Q3 2019, up from 3 in Q2 2019.
  • Funds reported $512K of InspireMD stock for Q3 2019, up 244% quarter-over-quarter.
  • 6 funds opened new InspireMD positions in Q3 2019 and 2 closed out, a net change of +4 holders.
  • The largest InspireMD buyer in Q3 2019 was Sabby Management, an estimated $805K added.
  • The largest InspireMD seller in Q3 2019 was Bank of New York Mellon, an estimated $82K sold.

Based on aggregated 13F filings for Q3 2019.